Powles, Thomas Loriot, Yohann Ravaud, Alain Vogelzang, Nicholas J. Duran, Ignacio Retz, Margitta De Giorgi, Ugo and Oudard, Stephane Bamias, Aristotelis Koeppen, Hartmut Leng, Ning Kadel, Edward E. Hegde, Priti S. Cui, Na Shen, Xiaodong Derleth, Christina Louise Green, Marjorie C. and Banchereau, Romain Mariathasan, Sanjeev Van Der Heijden, Michiel Simon, Atezolizumab (atezo) vs. chemotherapy (chemo) in platinum-treated
locally advanced or metastatic urothelial carcinoma (mUC): Immune
biomarkers, tumor mutational burden (TMB), and clinical outcomes from
the phase III IMvigor211 study., World Journal of Clinical Oncology, (36), 2018, Lippincott, Williams & Wilkins,